In the current work, we demonstrated that BHGJT inhibited lung cancer growth by inducing cell cycle arrest via the downregulation of CDK4 and Cyclin D1 and apoptosis via the AKT/GSK3β/β-catenin signaling pathways. Here, GSK3B is linked to lung carcinoma.